Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03350997 · ClinicalTrials.gov registry record · NA

Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control

A NA study of Metabolic Disease and Adipose Tissue, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT03350997 is a NA study of Metabolic Disease and Adipose Tissue that has completed, run by University of Michigan. The registered enrollment target is 22 participants, below the 4,189-participant average among 33 other Metabolic Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03350997, a NA study of Metabolic Disease and Adipose Tissue, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The study team will assess "free-living" 24h glucose control using continuous glucose monitors (CGM) over an 88h period on two separate occasions. Importantly, standardized meals will be provided and will be consumed at specific times each day of the CGM measurement period. These meals will be identical on day 1 and day 3 of measurement. Each subject will complete two CGM periods, which will be identical except for the calorie and macronutrient content of the post-exercise dinner. In addition, during trial 1, two CGM's will be worn, while only 1 CGM will be worn on trial 2.

Interventions

  • BEHAVIORAL Trial 2 Exercise
  • BEHAVIORAL Trial 1 Exercise

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2016-10-21
Est. Completion 2017-12-18
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03350997

The ClinicalTrials.gov registry entry for NCT03350997 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,189-participant average among 33 other Metabolic Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Metabolic Disease appearing as the primary indexed condition, and to 2 interventions - of which Trial 2 Exercise is the first listed.

NCT03350997 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03350997 about?

NCT03350997 is a clinical study titled "Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control". The study team will assess "free-living" 24h glucose control using continuous glucose monitors (CGM) over an 88h period on two separate occasions. Importantly, standardized meals will be provided and will be consumed at specific times each day of the CGM measurement period. These meals will be ident...

What is the current status of trial NCT03350997?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-10-21. Estimated completion is 2017-12-18.

What conditions does trial NCT03350997 study?

This clinical trial studies the following conditions: Metabolic Disease, Adipose Tissue.

What interventions are being tested in trial NCT03350997?

The interventions under investigation include: Trial 2 Exercise (BEHAVIORAL), Trial 1 Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03350997?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03350997 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.